Skip to content
PaperFren

mHealth

Does a diabetes phone app lower blood sugar over a year?

Holmen H, Torbjørnsen A, Wahl AK, et al. · JMIR mHealth and uHealth · 2014

Open access · cc by · source: Europe PMC

A year of using a diabetes self-management phone app, with or without a short course of nurse phone counselling, did not lower long-term blood sugar more than usual care.

How this study connects

Role on claims

Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.

Not yet placed on a claim. This paper has study layers, but no concept page yet cites it as support, challenge, or qualifier.

Study at a glance

Design
RCT — 3-arm open-label RCT (1:1:1 block randomisation): app only, app plus 4 months of phone health counselling, or usual care; 1-year follow-up
N
N=151 · 151 randomised (51 app, 50 app plus counselling, 50 control); HbA1c available for 120 at 1 year
Population
Adults in Norway with type 2 diabetes and HbA1c at or above 7.1%, recruited mainly via general practitioners
Outcome
Primary: change in HbA1c at 1 year; secondary: self-management (heiQ), quality of life (SF-36), depressive symptoms (CES-D), weight, diet and physical activity

Structured fields used in claim comparison tables when every cited study has a complete layer.

Inspect source passages

Does a diabetes phone app lower blood sugar over a year?

These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.

151 participants were randomised and included

One person withdrew consent, leaving a total of 151 participants to be included in the study; 51 were allocated to the FTA intervention, 50 to the FTA-HC intervention, and 50 to the control group.

120 participants had HbA1c data at 1 year

For the primary outcome (HbA 1c level), data were obtained for a total of 120 participants after the 1-year follow-up: 39 in the FTA group (dropout attrition 24%, 12/51), 40 in the FTA-HC group (dropout attrition 20%, 10/50), and 41 in the control group (dropout attrition 18%, 9/50).
Read passages in the original paper

Key findings

HbA1c fell in all three groups, but the change did not differ between either app group and usual care after 1 year. There were no between-group differences in weight, quality of life, depressive symptoms, diet or physical activity. The only positive secondary result was a small gain in the 'skill and technique acquisition' self-management domain in the app-plus-counselling group (B = 0.21). Only about a third of app users used it substantially, and, unexpectedly, participants aged 63 or over were more likely to be heavy users (OR 2.7).

Methodology

Adults with poorly controlled type 2 diabetes were randomised to usual care, a phone app linked by Bluetooth to a glucose meter (with diet, activity and goal-setting diaries), or the same app plus five monthly motivational-interviewing phone calls from a diabetes nurse during the first 4 months. Everyone kept seeing their GP as normal. Outcomes were measured at baseline, 4 months and 12 months, analysed by intention-to-treat and adjusted for age, gender and education.

Limitations

The trial was small and powered only for HbA1c, and 21% dropped out, so modest effects on secondary outcomes could be missed. Low use of the app, partly because the phones became outdated during the trial, means it tested offering the app rather than using it consistently. Participants could not be blinded, the control group happened to have more depressive symptoms at baseline, and volunteers motivated to join an mHealth study may not represent typical patients. The authors also question whether HbA1c is the right outcome for a self-management intervention.

Related papers in this topic

Same topic cluster — not a recommendation engine.